Prefilled Syringes Market is Expanding At A CAGR Of 11.95% From 2022 To 2030
Prefilled Syringes Industry Overview
The global prefilled syringes market size was valued at USD 18.43 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.95% from 2022 to 2030. Growing demand for efficient and easy-to-use drug delivery devices and increasing efforts of healthcare professionals to reduce hospital errors are the principal factors driving the market growth. The fast-paced development of feature-rich devices with underlying technological advancements extending safer and convenient self-injections for patients coupled with the impact of COVID-19 is expected to fuel the market growth during the forecast period.
With the current COVID - 19 outbreaks, a huge surge in immunizations is expected around the world. COVID-19 has spurred the development of prefilled syringes, especially for low-temperature storage. For instance, in September 2021, by demonstrating their glass prefilled syringes, which are ideal for use with mRNA doses that must be stored at ultralow temperatures, BD has positioned itself to unlock a new COVID-19 vaccination opportunity. BD also analyzed 2,000 syringes that were maintained at minus 20 and minus 40 degrees Celsius to see how temperatures affected the delivery devices. Moreover, syringes with various glass barrel coatings, volumes, and other variables that could influence the response to deep cold storage were investigated. As a result, due to the outbreak of the COVID-19 pandemic in 2020, sales of prefilled syringes increased globally.
Gather more insights about the market drivers, restrains and growth of the Global Prefilled Syringes market
A steep rise in the development of biological therapies is expected to boost industry growth. Biologic drugs including therapeutic vaccines are rapidly replacing the traditional therapeutic options owing to their increased efficiency, efficacy as well as patient safety with reduced side effects. The constant introduction of biologic drugs has given rise to the demand for innovative packaging solutions to maintain the potency of these drugs as they are extremely unstable. More than 60% of the biologic drugs are currently in the pipeline and preferred with parenteral administration as any interaction with food and digestive enzymes results in their deterioration. Thus, prefilled syringes are considered to be an ideal container for the storage of such drugs. Moreover, the growth of the biologic drug market has a direct positive impact on the prefilled syringes market.
Needlestick injuries are potentially dangerous as they may lead to the transmission of fatal diseases such as HIV and Hepatitis. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in June 2021, 37.7 million [30.2 million–45.1 million] individuals worldwide were living with HIV in 2020. Additionally, according to the same source, 28.2 million people had access to antiretroviral therapy as of June 2021 which is anticipated to boost the industry growth. Moreover, patients, as well as physicians are at a high risk of developing needle stick injuries during dose preparation. For instance, in March 2021, according to Occupation Safety and Health Administration (OSHA), every year, two million healthcare professionals (out of a total of 35 million) suffer from accidental needle-stick wounds around the world which are anticipated to boost the business scale in the ensuing years.
Furthermore, the Centers for Disease Control and Prevention (CDC) believes that using safety measures like prefilled syringes in hospitals might reduce sharps-related injuries by 60-88 %. This is because prefilled syringes are an easy way to reduce these injuries as the application of these devices bypasses the various dose preparation steps and can easily be disposed of. In the case of self-injection systems, innovative modifications such as hidden needles are helpful in reducing such injuries, resulting in increased patient convenience. As prefilled syringes provide safety without the added price, the usage of the same is expected to increase in the future.
Along with the aforementioned factors, a growing number of approvals for prefilled syringes by regulatory bodies, such as the U.S., FDA, and the EU along with market expansion is predicted to actively contribute to industry expansion. For instance, in September 2022, Owen Mumford Pharmaceutical Services, a company of Owen Mumford Ltd., received approval as a combination product in Asia for their safety device which is named 1mL UniSafe for pre-filled syringes. 1mL UniSafe has also received regulatory approval in Europe and the medicine is currently available on the market as a combination product with a rheumatoid arthritis drug. Moreover, 1mL UniSafe is a revolutionary, spring-free, patented safety mechanism for prefilled syringes that delivers a variety of benefits to both pharmaceutical firms and their patients which is anticipated to increase the demand for prefilled syringes in near future.
The growing popularity of auto-injectors owing to their advantages such as patient convenience and minimal contamination are factors that are expected to boost their growth during the period in focus. For instance, in July 2021, following the complete conclusion of development, Owen Mumford Pharmaceutical Services unveiled its innovative Aidaptus auto-injector platform. Aidaptus is a two-step, single-use auto-injector, spring-powered with a versatile design that fits both 2.25 mL and 1 mL prefilled glass syringes in the same base device, which is projected to drive market growth in the near future.
Increasing government investments in cutting-edge syringe production will drive market growth in the near future. For instance, in March 2022, the investment of USD 84.53 million in Hungary is intended to address the expanding global demand for prefill-able glass syringes. The extension is set to be complete by 2024 and it is expected to support the demand for the product in the near future.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Electronic Skin Market - The global electronic skin market size was valued at USD 4.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 20.5% from 2020 to 2027.
- Ureteral Stents Market - The global ureteral stents market size was valued at USD 422.9 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2020 to 2027.
Prefilled Syringes Market Segmentation
Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and regions:
Type Outlook (Revenue, USD Million, 2017 - 2030)
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
Material Outlook (Revenue, USD Million, 2017 - 2030)
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
Application Outlook (Revenue, USD Million, 2017 - 2030)
- Anaphylaxis
- Rheumatoid Arthritis
- Diabetes
- Others
Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)
- Hospitals
- Mail Order Pharmacies
- Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million, 2017 - 2030)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Market Share Insights
- August 2021: SCHOTT AG, a German specialty glass business along with its latest partnerSerum Institute of India purchased a 50% stake in the SCHOTT Kaisha joint venture in India.
- April 2021: Packaging Nipro Pharma CURACASE was introduced which is an individually packaged product in a compact and well-designed hard-plastic packaging that takes up the least amount of space in secondary packaging.
Key Companies profiled:
Some prominent players in the global prefilled syringes market include:
- Gerresheimer AG
- Schott Group
- Unilife Corporation
- Nipro Medical Corporation
- Owen Mumford
- Haselmeier AG
- BD & Others
Order a free sample PDF of the Prefilled Syringes Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Comments
Post a Comment